Viewing Study NCT00886457


Ignite Creation Date: 2025-12-24 @ 6:52 PM
Ignite Modification Date: 2025-12-27 @ 6:26 AM
Study NCT ID: NCT00886457
Status: TERMINATED
Last Update Posted: 2011-07-20
First Post: 2009-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 5-aza-2-deoxycytidine With Pegylated Interferon-alfa 2B: A Phase I Study With Molecular Correlates
Sponsor: Nevada Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module